Oncology

24 drugs are in development for Advanced Solid Tumor.

BioSniper AIPage evidence connected

Prepared research question

Which programs lead the Advanced Solid Tumor pipeline—and what evidence could change the picture?

Traceable citations · Unknowns marked

Drug Pipeline by Phase

Phase 2(4)

Drug	Company
imm-1-104	Immuneering Corp (IMRX)
RP-1664	Repare Therapeutics Inc. (RPTX)
RP-3467	Repare Therapeutics Inc. (RPTX)
TYRA-300	Tyra Biosciences, Inc. (TYRA)

Phase 1(12)

Drug	Company
AB308	Arcus Biosciences, Inc. (RCUS)
APR-1051	Aprea Therapeutics, Inc. (APRE)
BT7480	BICYCLE THERAPEUTICS PLC (BCYC)
chs-114	Coherus Oncology, Inc. (CHRS)
CLN-617	Cullinan Therapeutics, Inc. (CGEM)
FT825	FATE THERAPEUTICS INC (FATE)
NUV-1511	Nuvation Bio Inc. (NUVB)
NUV-868	Nuvation Bio Inc. (NUVB)
nxp800	Nuvectis Pharma, Inc. (NVCT)
PYX-201	Pyxis Oncology, Inc. (PYXS)
sw-682	SpringWorks Therapeutics, Inc. (SWTX)
wtx-124	Werewolf Therapeutics, Inc. (HOWL)

Phase 1/Phase 2(8)

Drug	Company
ATRN-119	Aprea Therapeutics, Inc. (APRE)
dcc-3084	Deciphera Pharmaceuticals, Inc. (DCPH)
LB101	Centessa Pharmaceuticals plc (CNTA)
lp-184	Lantern Pharma Inc. (LTRN)
lp-284	Lantern Pharma Inc. (LTRN)
ttx-mc138	Transcode Therapeutics, Inc. (RNAZ)
vilastobart	Xilio Therapeutics, Inc. (XLO)
xtx301	Xilio Therapeutics, Inc. (XLO)

About this indication

Oncology·MeSH: Ovarian Neoplasms (D010051)

Narrower concept of MeSH descriptor Ovarian Neoplasms

BioSniper tracks 24 drugs in development for Advanced Solid Tumor across 19 companies.

There are 145 clinical trials targeting Advanced Solid Tumor tracked by BioSniper.